unknown
Stage
1
Investors
About
Cergentis is now part of Solvias. Learn how our combined scientific expertise and superior service can elevate CMC testing for cell and gene therapy programs.
Explore Cergentis's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.